Purchases and Sales Made in Q2 2023 in Travere Therapeutics, Inc. (TVTX)
This table provides information about the institutional ownership of Travere Therapeutics, Inc. (TVTX) during Q2 2023. The information is specifically focused on institutions that hold shares of Travere Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2023
Q2 2023
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-500K- 44.45% |
$7.65M - $11.3M
|
625K
$13.2M
|
|
|
Jul 25, 2023
Q2 2023
|
Assenagon Asset Management S.A.
|
SELL
|
- |
-561K- 33.8% |
$8.58M - $12.7M
|
1.1M
$23.2M
|
|
|
Aug 14, 2023
Q2 2023
|
Polar Asset Management Partners Inc.
Toronto, A6 |
SELL
|
- |
-567K- 71.06% |
$8.68M - $12.8M
|
231K
$4.87M
|
|
|
Aug 11, 2023
Q2 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-590K- 27.5% |
$9.02M - $13.3M
|
1.56M
$32.8M
|
|
|
Aug 14, 2023
Q2 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-876K- 96.32% |
$13.4M - $19.8M
|
33.5K
$707K
|
|
|
Aug 14, 2023
Q2 2023
|
Great Point Partners LLC
Greenwich, CT |
SELL
|
- |
-943K- 94.02% |
$14.4M - $21.3M
|
60K
$1.27M
|